
IndraLab
Statements
reach
"Rapamycin, a potent autophagy inducer, inhibits the activation of NLRP3 inflammasomes and the production of IL-1β and IL-18 by eliminating mitochondrial ROS in macrophages [247], while 3-MA promotes the accumulation of mitochondrial ROS and the subsequent overactivation of the NLRP3 inflammasome [95]."
reach
"Rapamycin effectively downregulated the mRNA expression levels of tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), toll-like receptor 4 (TLR4), nucleotide binding oligomerization domain-like receptors (NLR) family pyrin domain-containing 3 (NLRP3), and Caspase-1, and suppressed the infiltration of neutrophils and macrophages."
reach
"In addition, studies have found that the administration of rapamycin at the early stage of the cytokine storm can prevent COVID-19 from progressing to a severe form by downregulating the senescence-associated secretory phenotype, mTOR-NLRP3-IL-1β axis, and IL-6 pathway, as well as decreasing the number of senescent T cells [251], suggesting that rapamycin as a potent autophagy activator may inhibit the NLRP3 inflammasome via autophagy induction."
reach
"In conclusion, our results suggest that sirolimus suppresses NLRP3 inflammasome, which is correlated with inhibited NF-κB activation and ROS production, and induced autophagy after pH1N1 infection; however, it is not clear whether other inflammasomes, such as AIM2, are also inhibited.Our experimental and clinical studies have revealed that dysregulated cytokine storm and excessive inflammatory cell infiltration are associated with disease severity [2–6]."